SUBSCRIBE
SUBSCRIBE

Neil Versel

Pictured: Shell game with business executives
Business
C-Suite Shuffle: Lonza Hires New CEO
Read the latest overview of people coming and going from executive positions at biopharma companies that BioSpace covers.
April 2, 2024
 · 
2 min read
 · 
Neil Versel
Pictured: Photo illustration featuring Avenzo Therapeutics CEO Athena Countouriotis
Flush With New $150M Investment, Avenzo Pursues Licensing Strategy
Avenzo’s founders, who led Turning Point through its $4.1 billion sale to BMS, want to in-license three clinical-stage oncology candidates by early 2026.
April 2, 2024
 · 
3 min read
 · 
Neil Versel
Pictured: Abstract collage of Statue of Liberty, temple and money
Policy
Chinese ADC Investment Boom in Question With China-U.S. R&D Relations in Flux
Alongside the abrupt departure of Chinese biotech WuXi from BIO, Congress is rattling sabers over perceived national security implications of the U.S.’s R&D relationship with the country.
April 1, 2024
 · 
4 min read
 · 
Neil Versel
Pictured: Shell game with business executives
Business
C-Suite Shuffle: A2 Bio, Bayer, BioNTech and More
See our latest overview of people coming and going from executive positions at biopharma companies covered by BioSpace.
March 26, 2024
 · 
4 min read
 · 
Neil Versel
Pictured: A red illustration of a businessman walk
Business
C-Suite Shuffle: Sumitomo, Kineta, IDRx and More
This is the latest rundown of people coming and going from executive positions at biopharma companies that BioSpace covers. This regular column highlights the hired, fired, retired, promoted or resigning, as well as those personally named in lawsuits.
March 13, 2024
 · 
6 min read
 · 
Neil Versel
Pictured: IVF collage/Nicole Bean for BioSpace
Policy
Alabama Ruling, Political Blowback Rattle In Vitro Fertilization Market
A controversial decision by the Alabama Supreme Court temporarily chilled IVF before igniting nationwide pushes to protect access to this type of fertility treatment, leaving drugmakers with questions.
March 12, 2024
 · 
5 min read
 · 
Neil Versel
Pictured: a collage depicting a secret layoff/ Nic
Business
Innovent Biologics Closes ADC-Focused Maryland Site, Lays Off Researchers
The Chinese biopharma company will be closing its U.S. headquarters and wet lab in the D.C. suburbs, according to scientists who recently lost their jobs.
March 11, 2024
 · 
1 min read
 · 
Neil Versel
Pictured: A collage of biopharma M&A/ Nicole Bean
Deals
Novartis, Ono Latest to Announce Billion-Dollar M&A Deals
Follow along as BioSpace keeps you up to date on the latest pharma and biotech M&As, from announcements to closings.
March 5, 2024
 · 
24 min read
 · 
Neil Versel
External view of AstraZeneca's headquarters building in Silicon Valley
Policy
AstraZeneca Loss in Court Not a Surprise, in Line with Other IRA Lawsuits
A federal court in Delaware ruled Friday that the pharma company had no “entitlement” to any price above what the buyer is willing to pay.
March 1, 2024
 · 
2 min read
 · 
Neil Versel
Pictured: A red illustration of a businessman walk
Business
C-Suite Shuffle: ReNAgade, Adaptimmune, Vittoria and More
Plus, last week Richard Gonzalez announced his retirement from AbbVie, PhRMA appointed Gilead’s O’Day to chair its board and Joseph Papa became president and CEO of Emergent.
February 28, 2024
 · 
5 min read
 · 
Neil Versel
Pictured: Handshake in front of raining money / Ta
Business
10 Multibillion-Dollar M&As That Closed Since July 2023
After a slow start to 2023 in an uncertain economic climate, biopharma mergers and acquisitions are on the rise.
February 21, 2024
 · 
6 min read
 · 
Neil Versel
Pictured: A photo of an empty federal courtroom/iS
Policy
AstraZeneca Case Leads Off Busy Year of Challenges to Medicare Drug Pricing Law
The first hearing on a potential injunction came the day before CMS is to release pricing proposals on 10 drugs.
February 1, 2024
 · 
5 min read
 · 
Neil Versel
Pictured: Illustration of office workers holding t
PhRMA, BIO Push Back Against Rare String of Setbacks
The two biopharmaceutical industry organizations entered Medicare price negotiations after the loss of several prominent members and executives.
January 23, 2024
 · 
4 min read
 · 
Neil Versel
Load More